MREO vs MTB · $48.7M cap vs P/E 12, rev $860.0M
Mereo BioPharma Group PLC ADR (MREO) versus M&T Bank Corporation (MTB) — a side-by-side from cached financials, not a winner call.
Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
M&T Bank Corporation (MTB) is a banks - regional company listed on US.
Latest reported MREO revenue for 2026-06-30 was $0. Net income was -$7.0M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. MREO currently screens at market cap $48.7M.
Latest reported MTB revenue for 2026-06-30 was $860.0M. Net income was $1.48B. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
MREO currently screens at market cap $48.7M. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
Not investment advice. Open the MREO and MTB stock pages for the full models.
Not investment advice.